Gut bacteria clues could lead to simple cancer test
NCT ID NCT06734156
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking at whether analyzing the bacteria in a person's stool can help detect colorectal cancer earlier, especially in people under 50 who are not routinely screened. Researchers will collect stool samples and diet information from 400 adults in Portugal recently diagnosed with colorectal cancer. The goal is to identify microbiome patterns linked to cancer and use them to create a non-invasive diagnostic tool.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple stool test that detects colorectal cancer earlier, potentially saving lives through timely treatment.
- What could go wrong
- This is an observational study, not a treatment trial. The test may not prove accurate enough for widespread use, and results may not apply outside Portugal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Champalimaud Foundation
RECRUITINGLisbon, Lisbon District, 1400-038, Portugal
-
Gulbenkian Institute for Molecular Medicine
RECRUITINGLisbon, Lisbon District, 1649-028, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why are more younger adults getting colorectal cancer? a national study digs into the data
- Could a gut bacteria transplant restore hair in alopecia areata?
- New drug combo aims to boost response in Hard-to-Treat colorectal cancer
- First-in-Class cancer drug targets Hard-to-Treat tumors
- New pill targets Hard-to-Treat cancers with a specific gene mutation
- AI eye on cancer: robot helps spot hidden polyps